152 related articles for article (PubMed ID: 30568176)
1. Lysyl oxidase enzymes mediate TGF-β1-induced fibrotic phenotypes in human skin-like tissues.
Huang M; Liu Z; Baugh L; DeFuria J; Maione A; Smith A; Kashpur O; Black Iii LD; Georgakoudi I; Whitfield ML; Garlick J
Lab Invest; 2019 Apr; 99(4):514-527. PubMed ID: 30568176
[TBL] [Abstract][Full Text] [Related]
2. Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase-like 4: New Evidence From Three-Dimensional Skin-like Tissues.
Huang M; Cai G; Baugh LM; Liu Z; Smith A; Watson M; Popovich D; Zhang T; Stawski LS; Trojanowska M; Georgakoudi I; Black LD; Pioli PA; Whitfield ML; Garlick J
Arthritis Rheumatol; 2020 May; 72(5):791-801. PubMed ID: 31705627
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 promotes matrix homeostasis by interacting with collagen and lysyl oxidase precursors and collagen cross-linking sites.
Rosini S; Pugh N; Bonna AM; Hulmes DJS; Farndale RW; Adams JC
Sci Signal; 2018 May; 11(532):. PubMed ID: 29844053
[TBL] [Abstract][Full Text] [Related]
5. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
[TBL] [Abstract][Full Text] [Related]
6. 5-HT
Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
[TBL] [Abstract][Full Text] [Related]
7. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva.
Hong HH; Uzel MI; Duan C; Sheff MC; Trackman PC
Lab Invest; 1999 Dec; 79(12):1655-67. PubMed ID: 10616214
[TBL] [Abstract][Full Text] [Related]
8. LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling.
Busnadiego O; González-Santamaría J; Lagares D; Guinea-Viniegra J; Pichol-Thievend C; Muller L; Rodríguez-Pascual F
Mol Cell Biol; 2013 Jun; 33(12):2388-401. PubMed ID: 23572561
[TBL] [Abstract][Full Text] [Related]
9. TGFβ-1 Induced Cross-Linking of the Extracellular Matrix of Primary Human Dermal Fibroblasts.
Semkova ME; Hsuan JJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498156
[TBL] [Abstract][Full Text] [Related]
10. CTRP6 inhibits fibrogenesis in TGF-β1-stimulated human dermal fibroblasts.
Fan RH; Zhu XM; Sun YW; Peng HZ; Wu HL; Gao WJ
Biochem Biophys Res Commun; 2016 Jul; 475(4):356-60. PubMed ID: 27155158
[TBL] [Abstract][Full Text] [Related]
11. Alpinetin Suppresses Effects of TGF-β1 on Stimulating the Production and Organization of Fibrotic Markers in Human Primary Dermal Fibroblasts.
Wikan N; Potikanond S; Nimlamool W
Cells; 2022 Sep; 11(17):. PubMed ID: 36078140
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
Xiao R; Yoshida N; Higashi Y; Lu QJ; Fukushige T; Kanzaki T; Kanekura T
J Dermatol; 2011 Apr; 38(4):345-53. PubMed ID: 21352343
[TBL] [Abstract][Full Text] [Related]
13. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
Nakai K; Karita S; Igarashi J; Tsukamoto I; Hirano K; Kubota Y
J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335
[TBL] [Abstract][Full Text] [Related]
14. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
15. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an
Merl-Pham J; Basak T; Knüppel L; Ramanujam D; Athanason M; Behr J; Engelhardt S; Eickelberg O; Hauck SM; Vanacore R; Staab-Weijnitz CA
Matrix Biol Plus; 2019 Feb; 1():100005. PubMed ID: 33543004
[TBL] [Abstract][Full Text] [Related]
17. Induction of LOX by TGF-β1/Smad/AP-1 signaling aggravates rat myocardial fibrosis and heart failure.
Lu M; Qin Q; Yao J; Sun L; Qin X
IUBMB Life; 2019 Nov; 71(11):1729-1739. PubMed ID: 31317653
[TBL] [Abstract][Full Text] [Related]
18. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S
Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
Ying M; Chen Y; Yuan B
Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidase-2 is a key regulator of human dermal fibroblasts: a potential therapeutic strategy for the treatment of skin fibrosis.
Zhang GY; Wu LC; Dai T; Chen SY; Wang AY; Lin K; Lin DM; Yang JQ; Cheng B; Zhang L; Gao WY; Li ZJ
Exp Dermatol; 2014 Sep; 23(9):639-44. PubMed ID: 24981855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
